Adriaan A Voors Selected Research

Adriaan A Voors Research Topics

Disease

399	Heart Failure 05/2024 - 07/2004
34	Myocardial Infarction 12/2023 - 12/2004
27	Inflammation (Inflammations) 09/2023 - 08/2006
21	Renal Insufficiency (Renal Failure) 01/2023 - 09/2005
18	Atrial Fibrillation 05/2024 - 01/2010
15	Hypertension (High Blood Pressure) 01/2023 - 05/2007
14	Iron Deficiencies 01/2022 - 04/2013
13	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 12/2002
13	Dyspnea (Shortness of Breath) 10/2022 - 01/2010
12	Heart Diseases (Heart Disease) 05/2024 - 10/2013
11	Anemia 11/2021 - 09/2005
10	Stroke (Strokes) 01/2023 - 05/2007
9	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2017
9	Weight Loss (Weight Reduction) 01/2023 - 05/2013
9	Systolic Heart Failure 01/2021 - 01/2011
9	Diabetes Mellitus 01/2021 - 03/2012
8	Hypotension (Low Blood Pressure) 04/2024 - 08/2015
8	Fibrosis (Cirrhosis) 09/2023 - 09/2009
7	Necrosis 01/2023 - 12/2011
7	Neoplasms (Cancer) 01/2023 - 09/2009
7	Chronic Renal Insufficiency 01/2022 - 01/2014
7	Left Ventricular Dysfunction 01/2018 - 01/2011
6	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2015
6	ST Elevation Myocardial Infarction 04/2024 - 08/2010
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2005
6	Pulmonary Hypertension 11/2021 - 10/2015
6	Body Weight (Weight, Body) 01/2019 - 05/2011
6	Infarction (Infarctions) 10/2013 - 03/2005
5	Hypertrophy 01/2020 - 07/2005
4	Disease Progression 04/2024 - 01/2018
4	Albuminuria 04/2024 - 11/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2023 - 01/2015
4	Obesity 01/2023 - 01/2017
4	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 10/2015
4	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 07/2006

Drug/Important Bio-Agent (IBA)

68	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2010
65	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 03/2006
32	DiureticsIBA 05/2024 - 01/2011
31	pro-brain natriuretic peptide (1-76)IBA 05/2024 - 01/2005
25	Erythropoietin FDA Link 10/2021 - 02/2004
24	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 09/2004
23	Natriuretic PeptidesIBA 05/2024 - 01/2005
22	vericiguatIBA 03/2024 - 01/2018
19	CreatinineIBA 04/2024 - 10/2006
17	SodiumIBA 05/2024 - 10/2013
16	Angiotensin Receptor AntagonistsIBA 04/2024 - 07/2007
15	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023 - 11/2014
14	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2010
14	RelaxinIBA 01/2023 - 04/2009
14	rolofyllineIBA 11/2019 - 05/2011
13	Mineralocorticoid Receptor AntagonistsIBA 05/2024 - 01/2011
13	empagliflozinIBA 04/2024 - 01/2020
12	Urea (Carbamide)FDA LinkGeneric 01/2021 - 09/2013
11	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 05/2011
10	Interleukin-6 (Interleukin 6)IBA 01/2023 - 08/2013
10	Hemoglobins (Hemoglobin)IBA 11/2021 - 04/2005
10	C-Reactive ProteinIBA 01/2021 - 06/2006
10	NitrogenIBA 01/2017 - 09/2013
10	Advanced Glycation End ProductsIBA 11/2012 - 12/2007
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2007
9	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 08/2013
9	Troponin T (Troponin T1)IBA 11/2021 - 11/2011
9	AlbuminsIBA 06/2021 - 11/2006
9	Purinergic P1 Receptor AntagonistsIBA 11/2019 - 05/2011
9	MicroRNAs (MicroRNA)IBA 01/2018 - 05/2014
8	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2021
8	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2021
8	Growth Differentiation Factor 15IBA 01/2022 - 08/2013
8	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 07/2007
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2019 - 12/2004
7	AdrenomedullinIBA 04/2024 - 06/2011
7	Soluble Guanylyl CyclaseIBA 01/2023 - 03/2013
7	SymportersIBA 01/2023 - 10/2019
7	omecamtiv mecarbilIBA 01/2023 - 01/2016
7	IronIBA 11/2019 - 01/2017
6	Spironolactone (Aldactone)FDA LinkGeneric 05/2024 - 01/2014
6	Cardiac MyosinsIBA 01/2023 - 01/2016
6	TroponinIBA 01/2021 - 11/2011
6	PotassiumIBA 01/2021 - 09/2014
6	Adenosine A1 ReceptorIBA 11/2019 - 05/2011
6	Ferritins (Ferritin)IBA 01/2018 - 04/2013
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2010 - 02/2004
5	finerenoneIBA 05/2024 - 01/2015
5	LigandsIBA 01/2023 - 03/2015
5	Fibroblast Growth Factor-23IBA 01/2022 - 01/2018
5	Transferrin (beta 2 Transferrin)IBA 01/2018 - 04/2013
5	Neprilysin (Neutral Endopeptidase)IBA 01/2017 - 08/2013
5	Valsartan (Vals)FDA Link 01/2016 - 08/2013
5	Galectin 3 (LGALS3)IBA 01/2016 - 09/2009
4	Eplerenone (Inspra)FDA LinkGeneric 05/2024 - 01/2015
4	SeleniumIBA 01/2024 - 01/2020
4	CytokinesIBA 09/2023 - 08/2014
4	Vitamin D FDA LinkGeneric 01/2023 - 06/2011
4	Lipocalin-2IBA 01/2022 - 10/2008
4	ChloridesIBA 12/2021 - 01/2016
4	CholesterolIBA 01/2021 - 08/2006

Therapy/Procedure

89	Therapeutics 05/2024 - 02/2004
32	Patient Readmission 03/2024 - 02/2012
14	Length of Stay 01/2023 - 01/2010
5	Percutaneous Coronary Intervention 04/2024 - 08/2010